Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



SIMPSON TODD E Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Granted 14,746 shares @ $0
Disposed/sold 1,106 shares @ $193.8689, valued at $214.4k
Disposed/sold 861 shares @ $193.8689, valued at $166.9k
Disposed/sold 1,540 shares @ $193.8689, valued at $298.6k
06/09/2023 4 SIMPSON TODD E (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.79, valued at $19.8k
04/04/2023 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Granted 1,395 shares @ $0
03/10/2023 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Sold 10,262 shares @ $175.89, valued at $1.8M
Sold 26,449 shares @ $176.71, valued at $4.7M
Sold 6,082 shares @ $177.37, valued at $1.1M
Exercised 42,793 options to buy @ $45.3, valued at $1.9M
02/28/2023 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Sold 20,000 shares @ $182.53, valued at $3.7M
02/21/2023 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Sold 39,946 shares @ $160.001, valued at $6.4M
Exercised 39,946 options to buy @ $39.15, valued at $1.6M
09/01/2022 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Sold 2,122 shares @ $154.4145, valued at $327.7k
Sold 2,064 shares @ $154.4145, valued at $318.7k
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/22/2022 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Sold 567 shares @ $144.3186, valued at $81.8k
12/22/2021 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Sold 345 shares @ $149.85, valued at $51.7k
11/05/2021 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Sold 40,232 shares @ $185, valued at $7.4M
Exercised 2,156 options to buy @ $46.37, valued at $100k
Exercised 40,232 options to buy @ $44.09, valued at $1.8M
11/02/2021 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Sold 33,564 shares @ $180.0001, valued at $6M
Exercised 33,564 options to buy @ $41.04, valued at $1.4M
09/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/18/2020 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Sold 33,669 shares @ $200, valued at $6.7M
Exercised 1,104 options to buy @ $45.3, valued at $50k
Exercised 33,669 options to buy @ $26.1, valued at $878.8k
11/09/2020 4 SIMPSON TODD E (CFO) has filed a Form 4 on Seagen Inc.
Txns: Sold 7,509 shares @ $180.368, valued at $1.4M
09/02/2020 4 SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Sold 2,065 shares @ $155.6942, valued at $321.5k
Sold 2,122 shares @ $155.6942, valued at $330.4k
Sold 4,452 shares @ $155.25, valued at $691.2k
Sold 5,480 shares @ $155.74, valued at $853.5k
Sold 1,640 shares @ $156.87, valued at $257.3k
Sold 50 shares @ $157.82, valued at $7.9k
Sold 469 shares @ $159.33, valued at $74.7k
08/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/07/2020 4 SIMPSON TODD E (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $12.84, valued at $321k
05/06/2020 4 SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Sold 14,167 shares @ $147.0005, valued at $2.1M
Sold 13,500 shares @ $162.45, valued at $2.2M
Sold 12,167 shares @ $163.36, valued at $2M
Sold 1,200 shares @ $164.1, valued at $196.9k
Exercised 3,831 options to buy @ $26.1, valued at $100k
Exercised 2,554 options to buy @ $39.15, valued at $100k
Exercised 2,436 options to buy @ $41.04, valued at $100k
Exercised 2,268 options to buy @ $44.09, valued at $100k
Exercised 1,103 options to buy @ $45.3, valued at $50k
Exercised 14,167 options to buy @ $12, valued at $170k
Exercised 26,867 options to buy @ $15.46, valued at $415.4k
04/21/2020 4 SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Granted 2,389 shares @ $0
Granted 1,439 shares @ $0
Disposed/sold 570 shares @ $139.9163, valued at $79.8k
12/23/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/15/2019 4 SIMPSON TODD E (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 22,000 options to buy @ $2.82, valued at $62k
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/04/2019 4 SIMPSON TODD E (See Remarks) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Granted 21,288 shares @ $0
Sold 2,092 shares @ $70.7993, valued at $148.1k
Granted 1,333 options to buy @ $72.64, valued at $96.8k
Granted 49,232 options to buy @ $72.64, valued at $3.6M
08/30/2019 4 SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Sold 5,909 shares @ $73.2144, valued at $432.6k
08/22/2019 4 SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Sold 12,500 shares @ $80, valued at $1M
04/09/2019 4 SIMPSON TODD E (CFO) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Sold 2,063 shares @ $78, valued at $160.9k
Sold 10,437 shares @ $78, valued at $814.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy